US 8808684
Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction
granted A61KA61K31/522A61K45/06
Quick answer
US patent 8808684 (Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/522, A61K45/06, A61K48/0008, A61K48/005